It's been a mediocre week for Artivion, Inc. ( NYSE:AORT ) shareholders, with the stock dropping 13% to US$25.42 in ...

Artivion (NYSE:AORT – Get Free Report) had its target price reduced by equities research analysts at Stifel Nicolaus from $33 ...

A downtrend has been apparent in Artivion (AORT) lately with too much selling pressure. The stock has declined 18.6% over the ...

Artivion, Inc. (NYSE:AORT – Get Free Report)’s stock price gapped down before the market opened on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $27.85, ...

Shares of medical device company Artivion (NYSE:AORT) fell 11.2% in the morning session after the company reported weak fourth-quarter 2024 results, as both revenue and EPS missed Wall Street's ...

Stifel lowered the firm’s price target on Artivion (AORT) to $30 from $33 and keeps a Buy rating on the shares after Q4 consensus sales ...

Reports Q4 revenue $97.3M, consensus $100.82M. “2024 was an excellent year for Artivion (AORT), marked by robust revenue and adjusted EBITDA ...

Q4 2024 Earnings Call Transcript February 24, 2025 Artivion, Inc. misses on earnings expectations. Reported EPS is $-0.39 EPS, expectations were $0.12. Operator: Greetings, and welcome to the Artivion ...

For the full year 2025, Artivion forecasts revenue between $420 million and $435 million, with the midpoint of $427.5 million falling below Wall Street's projection of $430.2 million. The revenue miss ...

Highlights: Achieved revenue of $97.3 million in the fourth quarter of 2024 versus $93.7 million in the fourth quarter of 2023, an increase of 4% ...

KENNESAW, Ga. (AP) — KENNESAW, Ga. (AP) — Artivion, Inc. (AORT) on Monday reported a loss of $16.5 million in its fourth quarter. The Kennesaw, Georgia-based company said it had a loss of 39 ...